ES3053040T3 - Method for continuous production of a granulate agent - Google Patents

Method for continuous production of a granulate agent

Info

Publication number
ES3053040T3
ES3053040T3 ES20722227T ES20722227T ES3053040T3 ES 3053040 T3 ES3053040 T3 ES 3053040T3 ES 20722227 T ES20722227 T ES 20722227T ES 20722227 T ES20722227 T ES 20722227T ES 3053040 T3 ES3053040 T3 ES 3053040T3
Authority
ES
Spain
Prior art keywords
active ingredient
particles
process space
solid particles
spray composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES20722227T
Other languages
English (en)
Spanish (es)
Inventor
Reinhard Nowak
Norbert Pöllinger
Annette Grave
Michael Jacob
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADD Advanced Drug Delivery Technologies AG
Original Assignee
ADD Advanced Drug Delivery Technologies AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADD Advanced Drug Delivery Technologies AG filed Critical ADD Advanced Drug Delivery Technologies AG
Application granted granted Critical
Publication of ES3053040T3 publication Critical patent/ES3053040T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
ES20722227T 2019-04-11 2020-04-09 Method for continuous production of a granulate agent Active ES3053040T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19168685.6A EP3721871A1 (de) 2019-04-11 2019-04-11 Verfahren zur kontinuierlichen herstellung eines wirkstoffgranulats
PCT/EP2020/060278 WO2020208202A1 (de) 2019-04-11 2020-04-09 Verfahren zur kontinuierlichen herstellung eines wirkstoffgranulats

Publications (1)

Publication Number Publication Date
ES3053040T3 true ES3053040T3 (en) 2026-01-16

Family

ID=66105207

Family Applications (1)

Application Number Title Priority Date Filing Date
ES20722227T Active ES3053040T3 (en) 2019-04-11 2020-04-09 Method for continuous production of a granulate agent

Country Status (13)

Country Link
US (1) US12551443B2 (https=)
EP (2) EP3721871A1 (https=)
JP (1) JP7602483B2 (https=)
CN (2) CN118649138A (https=)
AU (1) AU2020271280B2 (https=)
BR (1) BR112021020282A2 (https=)
CA (1) CA3144742A1 (https=)
DK (1) DK3952844T3 (https=)
ES (1) ES3053040T3 (https=)
IL (1) IL287121B1 (https=)
PL (1) PL3952844T3 (https=)
PT (1) PT3952844T (https=)
WO (1) WO2020208202A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102024107710A1 (de) * 2024-03-18 2025-09-18 Glatt Gesellschaft Mit Beschränkter Haftung Verfahren zur Herstellung von Tabletten
DE102024107712A1 (de) * 2024-03-18 2025-09-18 Glatt Gesellschaft Mit Beschränkter Haftung Vorrichtung zur Herstellung von Tabletten

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0739201T3 (da) 1994-01-14 2000-05-01 Ethypharm Lab Prod Ethiques Mikrogranuler af 5-nitro-imidazolderivater
DE19514187C1 (de) * 1995-04-21 1996-05-15 Degussa Verfahren und Vorrichtung zur Herstellung von Granulaten durch Wirbelschicht-Sprühgranulation
PT1117729E (pt) * 1998-07-21 2004-01-30 Vantico Ag Granulados escoaveis
US6117451A (en) 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
DE10004939C1 (de) 2000-02-05 2001-08-23 Lothar Moerl Steuerbare Gasanströmeinrichtung für Strahlschichtapparate
NZ526720A (en) * 2000-12-28 2007-11-30 Altus Pharmaceuticals Inc Crystallisation of whole antibodies or fragments thereof, on a large scale and a process allowing an alternative route for delivery of therapeutic antibodies
US6667054B2 (en) 2001-12-05 2003-12-23 Bernard Charles Sherman Metformin hydrochloride tablets
KR100592512B1 (ko) * 2002-11-22 2006-07-03 서울약품공업(주) 탐술로신 또는 약제학적으로 허용되는 이의 염을활성성분으로 하는 서방성 배뇨장애 치료제
DE10322062A1 (de) 2003-05-15 2004-12-02 Glatt Ingenieurtechnik Gmbh Verfahren und Vorrichtung zum Aufbringen von Flüssigkeiten in eine Feststoffströmung eines Strahlschichtapparates
ES2374191T3 (es) 2003-06-11 2012-02-14 Glatt Ingenieurtechnik Gmbh Procedimiento de preparación de granulados de enzimas y granulados de enzimas así obtenidos.
DE102005037630A1 (de) * 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
DE102007012105A1 (de) * 2007-03-13 2008-09-18 Add Advanced Drug Delivery Technologies Ltd. Pellets enthaltend pharmazeutische Substanz, Verfahren zu deren Herstellung und deren Verwendung
WO2010066385A1 (de) 2008-12-08 2010-06-17 Ratiopharm Gmbh Kompaktiertes moxifloxacin
WO2010106555A2 (en) 2009-03-17 2010-09-23 Shantilal, Doshi, Bimalkumar Directly compressible pre-granulated cellulose ether polymer and process for preparing the same
JP5922310B2 (ja) * 2013-07-25 2016-05-24 株式会社三和化学研究所 医薬製剤
WO2018034627A1 (en) * 2016-08-18 2018-02-22 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Pharmaceutical composition of antidiabetic tablet
EP3721870A1 (de) * 2019-04-11 2020-10-14 ADD Advanced Drug Delivery Technologies, Ltd. Verfahren zur kontinuierlichen herstellung eines wirkstoffgranulats

Also Published As

Publication number Publication date
IL287121A (en) 2022-01-01
JP2022528783A (ja) 2022-06-15
DK3952844T3 (da) 2025-11-17
WO2020208202A1 (de) 2020-10-15
CN118649138A (zh) 2024-09-17
AU2020271280B2 (en) 2025-07-24
IL287121B1 (en) 2026-01-01
JP7602483B2 (ja) 2024-12-18
US20220280432A1 (en) 2022-09-08
PT3952844T (pt) 2025-11-21
EP3952844B1 (de) 2025-08-27
CN114302711A (zh) 2022-04-08
CA3144742A1 (en) 2020-10-15
PL3952844T3 (pl) 2026-01-19
EP3952844A1 (de) 2022-02-16
BR112021020282A2 (pt) 2021-12-14
US12551443B2 (en) 2026-02-17
EP3721871A1 (de) 2020-10-14
AU2020271280A1 (en) 2021-12-09

Similar Documents

Publication Publication Date Title
US8895141B2 (en) Excipient for compressed tablets comprising novel spherical mannitol
ES3050631T3 (en) Method for continuous production of a granulate agent
CN107260683A (zh) 一种药物纳米颗粒传递系统
WO1996019200A1 (en) Sustained-release granular preparation and process for producing the same
JP2020511522A (ja) グルコキナーゼ活性化剤の経口製剤およびその製造方法
JP2006514879A (ja) 噴霧乾燥器およびインラインジェットミルを用いる粒子を製造するための方法および装置
US20140056985A1 (en) Method for production of particles of pharmaceutical substances and the use thereof
CN102946857A (zh) 制备意图口服给药的包含一种或多种活性成分的药物组合物的方法以及包含其的组合物
ES3053040T3 (en) Method for continuous production of a granulate agent
BR112019002007B1 (pt) Composição farmacêutica e uso de uma composição farmacêutica
US20100080849A1 (en) Pellets containing a pharmaceutical substance, method for the production thereof and use of the same
LJ et al. Formulation and in vitro evaluation of floating microspheres of anti-retro viral drug as a gastro retentive dosage form
JP4092587B2 (ja) 二軸混練機を用いた乾式コーティング
US20140163109A1 (en) Taste-masked ibupropen granules
Kar et al. Preparation, characterization, and evaluation of ropinirole hydrochloride loaded controlled release microspheres using solvent evaporation technique
Damor et al. A review on dual release oral reconstitutable suspension
Rashid Centrifugal granulating process for preparing drug-layered pellets based on microcrystalline cellulose beads
Rao et al. Development and in vitro evaluation of floating multiparticulate system of repaglinide
Singh Formulation and evaluation of sustained release dosage form of selected drug using release eudragits
Rathod Preparation and Evaluation of Gelucire Based Matrix Pellet Loaded with Antihypertensive Drug for Controlled Release
WO2009041945A1 (en) Coated compositions and methods for preparing same